Skip to content

COhort Study on A/H1N1 FLU During PREGnancy

Cohort Study to Evaluate Clinical Expression and Maternofetal Consequences of A/H1N1 Influenza in Pregnant Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01192737
Acronym
COFLUPREG
Enrollment
919
Registered
2010-09-01
Start date
2009-10-31
Completion date
2010-11-30
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza, Pregnancy

Keywords

pandemic, A/H1N1, pregnancy, cohort, vaccine, Influenza and Pregnancy

Brief summary

The purpose of this study is to measure the incidence of A/H1N1 Influenza infection in the mother and her child and to identify the determinants in pregnant women during pandemic period in three public maternities in Paris, France.

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \> 18 years * Pregnancy between 12 and 35 weeks of gestation, going in one of the following maternity cares: Port Royal, Necker, Saint Vincent de Paul * Provides written informed consent * Speaks and understands French * Covered by French Social Security

Exclusion criteria

* Not covered by French Social Security * Previous H1N1 influenza (virologically documented)

Design outcomes

Primary

MeasureTime frame
Frequency of A/H1N1 Influenza virus infection in pregnant women and impact of Flu on pregnancy outcome.1 year

Secondary

MeasureTime frame
Safety of Flu vaccine1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026